IMMUNE PROFILING AND CLINICAL OUTCOMES OF TIL THERAPYFOR HIGH-RISK BCG-EXPOSED NMIBC

Authors

Christopher W Guske, Lehigh Valley Health NetworkFollow

Publication/Presentation Date

5-2025

Volume

213

Issue

5

First Page

e500

Last Page

e500

Published In/Presented At

https://doi.org/10.1097/01.JU.0001109876.32161.cb

Department(s)

USF-LVHN SELECT Program, USF-LVHN SELECT Program Students

Document Type

Article